Aspirin-exacerbated respiratory disease.
Journal
Current opinion in immunology
ISSN: 1879-0372
Titre abrégé: Curr Opin Immunol
Pays: England
ID NLM: 8900118
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
11
02
2020
accepted:
28
02
2020
pubmed:
17
4
2020
medline:
5
10
2021
entrez:
17
4
2020
Statut:
ppublish
Résumé
Aspirin-exacerbated respiratory disease (AERD) classically presents with severe asthma, nasal polyposis, and respiratory exacerbations in response to cyclooxygenase (COX)-1 inhibition. Recent advances in our understanding of AERD have revealed multiple facets of immune dysregulation, including diminished prostaglandin E2 (PGE
Identifiants
pubmed: 32299015
pii: S0952-7915(20)30022-4
doi: 10.1016/j.coi.2020.02.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
9-13Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.